Ocular Therapeutix Inc. (OCUL) |
|
3.59 -0.16 (-4.27%)
|
01-23 16:00 |
|
Open: |
3.76 |
Pre. Close: |
3.75 |
|
High:
|
3.8 |
Low:
|
3.57 |
|
Volume:
|
344,187 |
Market Cap:
|
148M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.825 - 3.862 |
3.862 - 3.884 |
|
Low:
|
3.495 - 3.541 |
3.541 - 3.569 |
|
Close:
|
3.537 - 3.612 |
3.612 - 3.658 |
|
|
|
Technical analysis |
as of: 2019-01-23 4:30:01 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 5.49  One year: 6.32 |
| Support: |
Support1: 3.55 Support2: 2.95 |
| Resistance: |
Resistance1: 4.70 Resistance2: 5.41 |
| Pivot: |
4.00 |
| Moving Average: |
MA(5): 3.84 MA(20): 4.01
MA(100): 5.52 MA(250): 6.00 |
| MACD: |
MACD(12,26): -0.31 Signal(9): -0.32  |
| Stochastic oscillator: |
%K(14,3): 21.65 %D(3): 33.10 |
| RSI: |
RSI(14): 28.99 |
| 52-week: |
High: 8.28 Low: 3.55 Change(%): -42.0 |
| Average Vol(K): |
3-Month: 56291 10-Days: 36600 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.OCUL has closed below the lower band by 10.9%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 47.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to OCUL's normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
2019-01-10T16:01:00-05:00
Ocular Therapeutix(TM) Submits Supplemental New Drug Application (sNDA) for DEXTENZA® (dexamethasone ophthalmic insert) for the Treatment of Ocular Inflammation Following Ophthalmic Surgery
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
